2,690
Views
48
CrossRef citations to date
0
Altmetric
Basic Science Research Papers

Poly-ADP-ribosylation of HMGB1 regulates TNFSF10/TRAIL resistance through autophagy

, , , , , , , , & show all
Pages 214-224 | Received 10 Mar 2014, Accepted 10 Nov 2014, Published online: 01 Apr 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Qian Kong, Yunyao Li, Qixiang Liang, Jianwei Xie, Xinyu Li & Jianpei Fang. (2020) SIRT6-PARP1 is involved in HMGB1 polyADP-ribosylation and acetylation and promotes chemotherapy-induced autophagy in leukemia. Cancer Biology & Therapy 21:4, pages 320-331.
Read now
Tianwei Xu, Lihua Jiang & Zhaoxia Wang. (2019) The progression of HMGB1-induced autophagy in cancer biology. OncoTargets and Therapy 12, pages 365-377.
Read now
Minghua Yang, Changfeng Li, Shan Zhu, Lizhi Cao, Guido Kroemer, Herbert Zeh, Daolin Tang & Rui Kang. (2018) TFAM is a novel mediator of immunogenic cancer cell death. OncoImmunology 7:6.
Read now
José Yélamos, Miguel Galindo, Judith Navarro, Joan Albanell, Ana Rovira, Federico Rojo & Javier Oliver. (2016) Enhancing tumor-targeting monoclonal antibodies therapy by PARP inhibitors. OncoImmunology 5:1.
Read now

Articles from other publishers (44)

Ruochan Chen, Ju Zou, Xiao Zhong, Jie Li, Rui Kang & Daolin Tang. (2024) HMGB1 in the interplay between autophagy and apoptosis in cancer. Cancer Letters 581, pages 216494.
Crossref
H.H. Zeng, M. Ma, Y.L. Wang, M.H. Chen & D.B. Huang. (2023) Hyperoside attenuates carbon tetrachloride-induced hepatic fibrosis via the poly(ADP-ribose)polymerase-1-high mobility group protein 1 pathway. European Journal of Pharmacology 960, pages 176178.
Crossref
Ruochan ChenJu ZouRui KangDaolin Tang. (2023) The Redox Protein High-Mobility Group Box 1 in Cell Death and Cancer. Antioxidants & Redox Signaling 39:7-9, pages 569-590.
Crossref
Li-Hua Shao, Li Zhu, Meng Wang, Yue Ning, Feng-Qin Chen, Xia-Qing Gao, Chun-Ting Yang, Hong-Wei Wang & Hai-Long Li. (2023) Mechanisms involved in the HMGB1 modulation of tumor multidrug resistance (Review). International Journal of Molecular Medicine 52:2.
Crossref
Tianshu Yang, Wei Huang, Tianyu Ma, Xin Yin, Jingyao Zhang, Miaomiao Huo, Ting Hu, Tianyang Gao, Wei Liu, Die Zhang, Hefen Yu, Xu Teng, Min Zhang, Hao Qin, Yunkai Yang, Baowen Yuan & Yan Wang. (2023) The PRMT6/PARP1/CRL4B Complex Regulates the Circadian Clock and Promotes Breast Tumorigenesis. Advanced Science 10:14.
Crossref
Ruochan ChenJu ZouRui KangDoalin Tang. (2023) The redox protein HMGB1 in cell death and cancer. Antioxidants & Redox Signaling.
Crossref
Ruhua Wang, Yunong Fu, Menglin Yao, Xiaomeng Cui, Yan Zhao, Xinlan Lu, Yarui Li, Yiguang Lin & Shuixiang He. (2022) The HN1 / HMGB1 axis promotes the proliferation and metastasis of hepatocellular carcinoma and attenuates the chemosensitivity to oxaliplatin . The FEBS Journal 289:20, pages 6400-6419.
Crossref
Nirashaa T. Bound, Cassandra J. Vandenberg, Apriliana E. R. Kartikasari, Magdalena Plebanski & Clare L. Scott. (2022) Improving PARP inhibitor efficacy in high-grade serous ovarian carcinoma: A focus on the immune system. Frontiers in Genetics 13.
Crossref
L. Musacchio, C.M. Cicala, F. Camarda, V. Ghizzoni, E. Giudice, M.V. Carbone, C. Ricci, M.T. Perri, F. Tronconi, M. Gentile, V. Salutari, G. Scambia & D. Lorusso. (2022) Combining PARP inhibition and immune checkpoint blockade in ovarian cancer patients: a new perspective on the horizon?. ESMO Open 7:4, pages 100536.
Crossref
A. I. Stukan, A. Yu. Goryainova, S. V. Sharov, O. A. Goncharova, Z. K. Khachmamuk & V. V. Durov. (2022) Causes of resistance to PARP inhibitors and ways to overcome it. Case report of aggressive <i>BRCA</i>-related breast cancer. Tumors of female reproductive system 18:1, pages 54-65.
Crossref
Shi Song, Qianying Guo, Yiru Zhu, Peng Yuan, Zhiqiang Yan, Liying Yan & Jie Qiao. (2021) Exploring the role of autophagy during early human embryonic development through single-cell transcriptome and methylome analyses. Science China Life Sciences 65:5, pages 940-952.
Crossref
Ruochan Chen, Rui Kang & Daolin Tang. (2022) The mechanism of HMGB1 secretion and release. Experimental & Molecular Medicine 54:2, pages 91-102.
Crossref
Yujie Guo, Xiaoyan Xu, Tian Tang, Lin Sun, Xiong Zhang, Xia Shen, Dan Li, Lixin Wang, Libo Zhao & Peng Xie. (2022) miR-505 inhibits replication of Borna disease virus 1 via inhibition of HMGB1-mediated autophagy. Journal of General Virology 103:1.
Crossref
Lawrence Kasherman, Katherine Karakasis & Amit M. Oza. (2021) With Our Powers Combined. The Cancer Journal 27:6, pages 511-520.
Crossref
Ying Li, Yang Lv, Mengxiong Tang, Eun H. Choi, Junjie Wang, Guoqing Lv, Yu Zhu, Shubin Wang & Yajie Liu. (2021) Low‐temperature plasma‐jet‐activated medium inhibited tumorigenesis of lung adenocarcinoma in a 3D in vitro culture model. Plasma Processes and Polymers 18:11.
Crossref
Natalya V. Maluchenko, Alexey V. Feofanov & Vasily M. Studitsky. (2021) PARP-1-Associated Pathological Processes: Inhibition by Natural Polyphenols. International Journal of Molecular Sciences 22:21, pages 11441.
Crossref
Brady Anderson, Mary Vue, Nya Gayluak, Sarah Jane Brown, Lynne T. Bemis & Glenn E. SimmonsJr.Jr.. (2021) Targeting HMGB1 in the Treatment of Non-Small Cell Lung Adenocarcinoma. Onco 1:1, pages 25-37.
Crossref
Deepika Singh, Mallika Tewari, Sunita Singh & Gopeshwar Narayan. (2021) Revisiting the role of TRAIL/TRAIL-R in cancer biology and therapy. Future Oncology 17:5, pages 581-596.
Crossref
Chuan Yang, Ting Feng, Fang Lin, Tinxiang Gong, Shuo Yang, Yuhong Tao & Hong Li. (2020) Long noncoding RNA TANCR promotes γδ T cells activation by regulating TRAIL expression in cis. Cell & Bioscience 10:1.
Crossref
Mahendra Pal Singh, Tejinder Pal Khaket, Vivek K. Bajpai, Saleh Alfarraj, Se-Gie Kim, Lei Chen, Yun Suk Huh, Young-Kyu Han & Sun Chul Kang. (2020) Morin Hydrate Sensitizes Hepatoma Cells and Xenograft Tumor towards Cisplatin by Downregulating PARP-1-HMGB1 Mediated Autophagy. International Journal of Molecular Sciences 21:21, pages 8253.
Crossref
Elizabeth K. Lee & Ursula A. Matulonis. (2020) PARP Inhibitor Resistance Mechanisms and Implications for Post-Progression Combination Therapies. Cancers 12:8, pages 2054.
Crossref
Man Sup Kwak, Hee Sue Kim, Bin Lee, Young Hun Kim, Myoungsun Son & Jeon-Soo Shin. (2020) Immunological Significance of HMGB1 Post-Translational Modification and Redox Biology. Frontiers in Immunology 11.
Crossref
Zhiliang Li, Zengwu Shao, Songfeng Chen, Donghua Huang, Yizhong Peng, Sheng Chen & Kaige Ma. (2019) TIGAR impedes compression‐induced intervertebral disc degeneration by suppressing nucleus pulposus cell apoptosis and autophagy. Journal of Cellular Physiology 235:2, pages 1780-1794.
Crossref
Elizabeth K. Lee & Panagiotis A. Konstantinopoulos. (2020) PARP inhibition and immune modulation: scientific rationale and perspectives for the treatment of gynecologic cancers. Therapeutic Advances in Medical Oncology 12, pages 175883592094411.
Crossref
Yunyao Li, Jianwei Xie, Xinyu Li & Jianpei Fang. (2019) Poly (ADP‑ribosylation) of HMGB1 facilitates its acetylation and promotes HMGB1 translocation‑associated chemotherapy‑induced autophagy in leukaemia cells. Oncology Letters.
Crossref
So-Ra Lee, Khong Trong Quan, Hee Sun Byun, InWha Park, Kidong Kang, Xuezhe Piao, Eunjin Ju, Hyunju Ro, MinKyun Na & Gang Min Hur. (2019) Accelerated degradation of cFLIPL and sensitization of the TRAIL DISC-mediated apoptotic cascade by pinoresinol, a lignan isolated from Rubia philippinensis. Scientific Reports 9:1.
Crossref
Singh, Cho, Kim, Baek, Lee & Kang. (2019) Morin Hydrate Reverses Cisplatin Resistance by Impairing PARP1/HMGB1-Dependent Autophagy in Hepatocellular Carcinoma. Cancers 11:7, pages 986.
Crossref
Minghua Yang, Pan ChenJiao LiuShan ZhuGuido Kroemer, Daniel J. Klionsky, Michael T. Lotze, Herbert J. Zeh, Rui Kang & Daolin Tang. (2019) Clockophagy is a novel selective autophagy process favoring ferroptosis. Science Advances 5:7.
Crossref
Meihong Deng, Melanie J Scott, Jie Fan & Timothy R Billiar. (2019) Location is the key to function: HMGB1 in sepsis and trauma-induced inflammation. Journal of Leukocyte Biology 106:1, pages 161-169.
Crossref
Qian LI, Zhuo-ming LI, Shu-ya SUN, Lu-ping WANG, Pan-xia WANG, Zhen GUO, Han-wei YANG, Jian-tao YE, Jing LU & Pei-qing LIU. (2018) PARP1 interacts with HMGB1 and promotes its nuclear export in pathological myocardial hypertrophy. Acta Pharmacologica Sinica 40:5, pages 589-598.
Crossref
Yingting Liu, Pan Chen, Linyong Xu, Meifei Ouyang, Dan Wang, Daolin Tang, Liangchun Yang, Min Xie, Lizhi Cao & Minghua Yang. (2019) Extracellular HMGB1 prevents necroptosis in acute myeloid leukemia cells. Biomedicine & Pharmacotherapy 112, pages 108714.
Crossref
Liubing Hu, Yan Wang, Zui Chen, Liangshun Fu, Sheng Wang, Xinyue Zhang, Pengchao Zhang, Xueping Lu, Huiyang Jie, Manmei Li, Yifei Wang & Zhong Liu. (2019) Hsp90 Inhibitor SNX-2112 Enhances TRAIL-Induced Apoptosis of Human Cervical Cancer Cells via the ROS-Mediated JNK-p53-Autophagy-DR5 Pathway. Oxidative Medicine and Cellular Longevity 2019, pages 1-26.
Crossref
Hee Sun Byun, Wei Zhou, InWha Park, Kidong Kang, So-Ra Lee, Xuezhe Piao, Jin Bong Park, Taeg Kyu Kwon, MinKyun Na & Gang Min Hur. (2018) C-27-carboxylated oleanane triterpenoids up-regulate TRAIL DISC assembly via p38 MAPK and CHOP-mediated DR5 expression in human glioblastoma cells. Biochemical Pharmacology 158, pages 243-260.
Crossref
Xun Yuan, Ambikai Gajan, Qian Chu, Hua Xiong, Kongming Wu & Gen Sheng Wu. (2018) Developing TRAIL/TRAIL death receptor-based cancer therapies. Cancer and Metastasis Reviews 37:4, pages 733-748.
Crossref
Arturo Contis-Montes de Oca, Estefanía Rodarte-Valle, Martha Cecilia Rosales-Hernández, Edgar Abarca-Rojano, Saúl Rojas-Hernández, Manuel Jonathan Fragoso-Vázquez, Jessica Elena Mendieta-Wejebe, Ana María Correa-Basurto, Ismael Vázquez-Moctezuma & José Correa-Basurto. (2018) N -(2′-Hydroxyphenyl)-2-propylpentanamide (OH-VPA), a histone deacetylase inhibitor, induces the release of nuclear HMGB1 and modifies ROS levels in HeLa cells . Oncotarget 9:70, pages 33368-33381.
Crossref
Harriet Gaskell, Xiaodong Ge & Natalia Nieto. (2018) High‐Mobility Group Box‐1 and Liver Disease. Hepatology Communications 2:9, pages 1005-1020.
Crossref
Likhitha Kolla, David S. Heo, Daniel P. Rosenberg, Sara A. Barlow, Anna A. Maximova, Emily E. Cassio & William J. Buchser. (2018) High content screen for identifying small-molecule LC3B-localization modulators in a renal cancer cell line. Scientific Data 5:1.
Crossref
Young Hun Kim, Man Sup Kwak, Jae Min Shin, Ria Aryani Hayuningtyas, Ji Eun Choi & Jeon-Soo Shin. (2018) Inflachromene inhibits autophagy through modulation of Beclin 1 activity. Journal of Cell Science.
Crossref
Rui Kang & Daolin Tang. 2017. Molecules, Systems and Signaling in Liver Injury. Molecules, Systems and Signaling in Liver Injury 133 158 .
Lelin Hu, Hao Wang, Li Huang, Yong Zhao & Junjie Wang. (2016) Crosstalk between autophagy and intracellular radiation response (Review). International Journal of Oncology 49:6, pages 2217-2226.
Crossref
Anneli Andersson, Andrej Bluwstein, Nitin Kumar, Federico Teloni, Jens Traenkle, Michael Baudis, Matthias Altmeyer & Michael O. Hottiger. (2016) PKCα and HMGB1 antagonistically control hydrogen peroxide-induced poly-ADP-ribose formation. Nucleic Acids Research 44:16, pages 7630-7645.
Crossref
Adriano Aguzzi & Matthias Altmeyer. (2016) Phase Separation: Linking Cellular Compartmentalization to Disease. Trends in Cell Biology 26:7, pages 547-558.
Crossref
Rui Ge, Lin Liu, Wei Dai, Weigang Zhang, Yuqi Yang, Huina Wang, Qiong Shi, Sen Guo, Xiuli Yi, Gang Wang, Tianwen Gao, Qi Luan & Chunying Li. (2016) Xeroderma Pigmentosum Group A Promotes Autophagy to Facilitate Cisplatin Resistance in Melanoma Cells through the Activation of PARP1. Journal of Investigative Dermatology 136:6, pages 1219-1228.
Crossref
Nicolas Preyat & Oberdan Leo. (2016) Complex role of nicotinamide adenine dinucleotide in the regulation of programmed cell death pathways. Biochemical Pharmacology 101, pages 13-26.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.